A review of the Clinical Economics of Irritable Bowel Syndrome

This item is provided by the institution :

Repository :
Annals of Gastroenterology
see the original item page
in the repository's web site and access all digital files if the item*

2007 (EN)
A review of the Clinical Economics of Irritable Bowel Syndrome (EN)

., Beth A. Hahn

SUMMARY Gastroenterologists are increasingly called upon to consider the clinical economic aspects of disease and intervention strategies in their medical decision-making. The clinical economics of IBS have not been comprehensively reviewed since 1997. The current paper integrates post-1997 findings on the direct, indirect, and intangible costs of IBS with earlier research and considers the extent to which knowledge of the clinical economics of IBS has advanced. The data show that little progress has been made in quantifying the direct and indirect costs of IBS in monetary terms. However, understanding of the impact on patients’ quality of life and functional ability has advanced. Recent data are consistent with previous findings in suggesting that IBS can significantly impair patients’ well-being and ability to function both at home and in the workplace. The magnitude of impairment of quality of life and functional ability is related to the severity and/or frequency of bowel symptoms. New evidence also suggests that psychological symptoms in IBS predict quality-of-life impairment. Thus, understanding of some of the clinical economic aspects of IBS has advanced, although more work is needed. Developing a solid foundation of clinical economic data regarding IBS will be particularly important in providing a baseline against which to evaluate IBS-specific pharmacotherapies now in development. Key words: Clinical economics, Quality of life, resource utilization (EN)




Hellenic Society of Gastroenterology (EN)

Annals of Gastroenterology; Volume 15, No 3 (2002) (EN)

*Institutions are responsible for keeping their URLs functional (digital file, item page in repository site)